Team Biographies 

Divider Rule


None of the following persons on the TobPRAC research team in any capacity has a known conflict of interest with the stated missions of TobPRAC or the National Cancer Institute. None of the individuals is, or has been, remunerated in any form by a tobacco company, a cigarette manufacturer, an organization promoting tobacco or any product containing tobacco or tobacco carcinogens.


              
  • Peter G. Shields, MD, Principal Investigator
    Georgetown University, Washington, DC
  •           
  • Dorothy Hatsukami, PhD, Co-Principal Investigator
    University of Minnesota, Minneapolis/St. Paul, MN
  •           
  • Gregory N. Connolly, DMD, MPH, Site-Principal Investigator
    Harvard School of Public Health, Boston, MA
  •           
  • Michael Cummings, PhD, MPH, Site-Principal Investigator
    Roswell Park Cancer Institute, Buffalo, NY
  •           
  • Richard Higby, PhD, Site-Principal Investigator
    Arista Laboratories, Richmond VA
  •           
  • Stephen Hecht, PhD, Site-Principal Investigator
    University of Minnesota Cancer Center, Minneapolis, MN
  •           
  • Michael Tacelosky, Site-Principal Investigator
    tobacco.org, Washington, DC
  •           
  • Richard J. O'Connor, PhD, Investigator
    Roswell Park Cancer Institute, Buffalo, NY
  •           
  • Jeanine M.Genkinger, PhD, MHS, Investigator
    Georgetown University, Washington, DC
  •           
  • Vaughan Rees, PhD, Investigator
    Harvard School of Public Health, Boston MA
  •           
  • Catalin Marian, MD, PhD, Scientific Program Manager
    TobPRAC NCI Contract, and Research Instructor, Georgetown University

Tobacco Expert Consulting Committee
              
  • Mitchell Zeller, JD - Chair, Tobacco Expert Consulting Committee
    Vice President for Policy and Strategic Communications
    Pinney Associates
  •           
  • David Liddell Ashley, PhD, Chief
    Emergency Response and Air Toxicants Branch
    National Center for Environmental Health
    Centers for Disease Control and Prevention
  •           
  • Harvey J. Clewell III, PhD, DABT
    Director, Center for Human Health Assessment
    The Hamner Institutes for Health Sciences
  •           
  • Thomas Evan Eissenberg, PhD, Associate Professor
    Dept. of Psychology and Institute of Drug and Alcohol Studies
    Virginia Commonwealth University
  •           
  • William A. Farone, PhD
    Applied Power Concepts, Inc.
  •           
  • Curtis C. Harris M.D., Chief
    Laboratory of Human Carcinogenesis
    National Cancer Institute
  •           
  • Murray Kaiserman, PhD, Director
    Office of Research, Surveillance and Evaluation Tobacco Control Program
    Health Canada
  •           
  • Scott J. Leischow, PhD, Associate Director Behavioral and Social Science
    Research, The University of Arizona
    Arizona Cancer Center
  •           
  • Ellen Peters, PhD, Senior Research Scientist
    Decision Research
  •           
  • Jonathon Samet, MD, MS
    Professor and Chair, Department of Preventative Medicine
    Director, USC Institute for Global Health, Keck School of Medicine
    USC/Norris Comprehensive Cancer Center
  •           
  • Maxine Stitzer, Ph.D.
    Professor, Psychiatry and Behavioral Sciences
    Johns Hopkins University School of Medicine
  •           
  • Rita Schoeny, PhD, Senior Science Advisor
    Office of Water, U.S. Environmental Protection Agency
  •           
  • Xifeng Wu, MD, PhD, Ashbel Smith Professor of Epidemiology
    Department of Epidemiology
    UT MD Anderson Cancer Center
  •           
  • Steven Belinsky, PhD, Director
    Lung Cancer Program
    Lovelace Respiratory Research Institute